Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q1 2018 · 10-Q
Revenue$0.00$0.00— vs Q1 2017 Net Income-$45.00K-$45.00KN/M vs Q1 2017 EPS Diluted-$0.04-$0.04N/M vs Q1 2017 Operating Income-$21,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
ended May 31, 2018 · filed Jul 16, 2018 · 46 d after period end